| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 914 | 2016 |
| Gene expression profiling of the tumor microenvironment during breast cancer progression XJ Ma, S Dahiya, E Richardson, M Erlander, DC Sgroi Breast cancer research 11, 1-18, 2009 | 764 | 2009 |
| Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology I Qaddoumi, W Orisme, J Wen, T Santiago, K Gupta, JD Dalton, B Tang, ... Acta neuropathologica 131, 833-845, 2016 | 392 | 2016 |
| A five-gene molecular grade index and HOXB13: IL17BR are complementary prognostic factors in early stage breast cancer XJ Ma, R Salunga, S Dahiya, W Wang, E Carney, V Durbecq, A Harris, ... Clinical cancer research 14 (9), 2601-2608, 2008 | 373 | 2008 |
| Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes L Marselli, J Thorne, S Dahiya, DC Sgroi, A Sharma, S Bonner-Weir, ... PloS one 5 (7), e11499, 2010 | 330 | 2010 |
| Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy TM Johanns, CA Miller, IG Dorward, C Tsien, E Chang, A Perry, ... Cancer discovery 6 (11), 1230-1236, 2016 | 306 | 2016 |
| Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide S Walpole, AL Pritchard, CM Cebulla, R Pilarski, M Stautberg, ... JNCI: Journal of the National Cancer Institute 110 (12), 1328-1341, 2018 | 250 | 2018 |
| Comprehensive genomic profiling of 282 pediatric low‐and high‐grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures A Johnson, E Severson, L Gay, JA Vergilio, J Elvin, J Suh, S Daniel, ... The oncologist 22 (12), 1478-1490, 2017 | 221 | 2017 |
| Maintenance of age in human neurons generated by microRNA-based neuronal conversion of fibroblasts CJ Huh, B Zhang, MB Victor, S Dahiya, LFZ Batista, S Horvath, AS Yoo elife 5, e18648, 2016 | 219 | 2016 |
| BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma S Dahiya, DH Haydon, D Alvarado, CA Gurnett, DH Gutmann, JR Leonard Acta neuropathologica 125, 901-910, 2013 | 187 | 2013 |
| Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort BS Wittner, DC Sgroi, PD Ryan, TJ Bruinsma, AM Glas, A Male, S Dahiya, ... Clinical Cancer Research 14 (10), 2988-2993, 2008 | 183 | 2008 |
| Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males T Sun, NM Warrington, J Luo, MD Brooks, S Dahiya, SC Snyder, ... The Journal of clinical investigation 124 (9), 4123-4133, 2014 | 174 | 2014 |
| Epidermal growth factor receptor extracellular domain mutations in glioblastoma present opportunities for clinical imaging and therapeutic development ZA Binder, AH Thorne, S Bakas, EP Wileyto, M Bilello, H Akbari, ... Cancer cell 34 (1), 163-177. e7, 2018 | 172 | 2018 |
| Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas M Pekmezci, DE Reuss, AC Hirbe, S Dahiya, DH Gutmann, ... Modern Pathology 28 (2), 187-200, 2015 | 172 | 2015 |
| Meningioma: a review of clinicopathological and molecular aspects K Huntoon, AMS Toland, S Dahiya Frontiers in oncology 10, 579599, 2020 | 164 | 2020 |
| Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR EEW Cohen, MW Lingen, LE Martin, PL Harris, BW Brannigan, ... Clinical cancer research 11 (22), 8105-8108, 2005 | 162 | 2005 |
| HOXB13 promotes ovarian cancer progression J Miao, Z Wang, H Provencher, B Muir, S Dahiya, E Carney, CO Leong, ... Proceedings of the National Academy of Sciences 104 (43), 17093-17098, 2007 | 144 | 2007 |
| An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma AD Gujar, S Le, DD Mao, DYA Dadey, A Turski, Y Sasaki, D Aum, J Luo, ... Proceedings of the National Academy of Sciences 113 (51), E8247-E8256, 2016 | 142 | 2016 |
| Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition L Nobre, M Zapotocky, V Ramaswamy, S Ryall, J Bennett, D Alderete, ... JCO precision oncology 4, 561-571, 2020 | 132 | 2020 |
| Midkine activation of CD8+ T cells establishes a neuron–immune–cancer axis responsible for low-grade glioma growth X Guo, Y Pan, M Xiong, S Sanapala, C Anastasaki, O Cobb, S Dahiya, ... Nature communications 11 (1), 2177, 2020 | 132 | 2020 |
Arie PerryProfessor and Director of Neuropathology, UCSFAdresă de e-mail confirmată pe ucsf.edu
